Literature DB >> 6389878

Vaccination against 77 capsular types of Klebsiella aerogenes with polyvalent Klebsiella vaccines.

R J Jones, E A Roe.   

Abstract

A method is described for producing monovalent and polyvalent vaccines from culture filtrates of Klebsiella aerogenes. With a single injection, each monovalent vaccine protected mice against lethal intraperitoneal challenge by more than 30 capsular types; and polyvalent vaccines containing 2-12 monovalent components protected against 46-61 of the 77 capsular types of K. aerogenes. One vaccine with 12 components, administered in two doses, induced full protection against 71 types and protected half of the mice challenged with the other six types.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6389878     DOI: 10.1099/00222615-18-3-413

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  7 in total

1.  Progress towards the development of Klebsiella vaccines.

Authors:  Myeongjin Choi; Sharon M Tennant; Raphael Simon; Alan S Cross
Journal:  Expert Rev Vaccines       Date:  2019-06-28       Impact factor: 5.217

2.  Production of an extracellular toxic complex by various strains of Klebsiella pneumoniae.

Authors:  D C Straus
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

3.  Passive immunization of mice against Klebsiella aerogenes.

Authors:  E A Roe; R J Jones; R E Dyster
Journal:  Br J Exp Pathol       Date:  1986-02

4.  Phagocytosis and Killing of Carbapenem-Resistant ST258 Klebsiella pneumoniae by Human Neutrophils.

Authors:  Scott D Kobayashi; Adeline R Porter; David W Dorward; Amanda J Brinkworth; Liang Chen; Barry N Kreiswirth; Frank R DeLeo
Journal:  J Infect Dis       Date:  2016-01-14       Impact factor: 5.226

5.  Antibody-Mediated Killing of Carbapenem-Resistant ST258 Klebsiella pneumoniae by Human Neutrophils.

Authors:  Scott D Kobayashi; Adeline R Porter; Brett Freedman; Ruchi Pandey; Liang Chen; Barry N Kreiswirth; Frank R DeLeo
Journal:  mBio       Date:  2018-03-13       Impact factor: 7.867

6.  Production of a Promising Biosynthetic Self-Assembled Nanoconjugate Vaccine against Klebsiella Pneumoniae Serotype O2 in a General Escherichia Coli Host.

Authors:  Zhehui Peng; Jun Wu; Kangfeng Wang; Xin Li; Peng Sun; Lulu Zhang; Jing Huang; Yan Liu; Xiaoting Hua; Yunsong Yu; Chao Pan; Hengliang Wang; Li Zhu
Journal:  Adv Sci (Weinh)       Date:  2021-05-24       Impact factor: 16.806

7.  Immunogenic characteristics of the outer membrane phosphoporin as a vaccine candidate against Klebsiella pneumoniae.

Authors:  Gaowei Hu; Xue Chen; Wenhui Chu; Zhe Ma; Yingjie Miao; Xi Luo; Yongqian Fu
Journal:  Vet Res       Date:  2022-01-21       Impact factor: 3.683

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.